With the changing disease spectrum, atherosclerosis has become increasingly prevalent
worldwide and the associated diseases have emerged as the leading cause of death. Due …

Atherosclerosis remains a significant global health challenge, with its related conditions as
the leading cause of death, underscoring the urgent need for enhanced diagnostic and …

Background Micheliolide (MCL), which is the active metabolite of parthenolide, has
demonstrated promising clinical application potential. However, the effects and underlying …

Curcumin potentiates the stabilization of atherosclerotic plaques by polarizing
macrophages, but its non-specific targeting hinders its clinical application. We aim to …

Atherosclerosis is the primary cause of cardiovascular events such as heart attacks and
strokes. However, current medical practice lacks non‐invasive, reliable approaches for both …

Cardiovascular disease (CVD) is the primary cause of morbidity and mortality in the Western
world. Multiple molecular and cellular processes underpinning the pathogenesis of CVD are …

Plaque rupture in atherosclerosis (AS) is a major cause of acute cardiovascular events.
Macrophage-induced inflammatory responses and accumulation of excess reactive oxygen …

Cardiovascular diseases (CVDs) represent a prominent cause of global mortality, posing
considerable challenges for traditional therapies due to their limited bioavailability and …

Hyperlipidemia (HLP) is a metabolic disorder caused by abnormal lipid metabolism.
Recently, the prevalence of HLP caused by poor dietary habits in the population has been …

The pathogenesis of atopic dermatitis (AD) points to skin barrier dysfunction as a critical
piece of the puzzle. Deficiencies in fatty acids and ceramides—key elements of the skin …